REVA Medical, Inc. announced the first implant of the Fantom bioresorbable scaffold (BRS) in Italy. The procedure was conducted by Dr. Bernardo Cortese at the Fatebenefratelli Hospital in Milan. Fantom is the only bioresorbable scaffold made from Tyrocore, REVA’s proprietary tyrosine-derived polymer designed specifically for vascular scaffold applications. Tyrocore is visible under x-ray, making Fantom the first and only BRS that is x-ray visible. Additionally, Fantom offers a thin profile while retaining radial strength. Thinner profiles have been shown to improve deliverability and support vessel healing. Previously reported results from the FANTOM II clinical study have shown low Major Adverse Cardiac Event (MACE) rates of 4.2% at 12 months in 240 patients and 5.6% at 24 months in an interim, 125 patient data set.